InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Wednesday Nov 23, 2022 - 2:55 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for Glioblastoma Multiforme (‘GBM’), according to CNS Pharmaceuticals CEO John Climaco. The company’s focus and…

Continue Reading

Wednesday Nov 23, 2022 - 1:54 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)

Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept to deployment. “With this collaboration, Cepton seeks to accelerate the development of lidar solutions for assisted and autonomous driving for global consumers. NVIDIA DRIVE Sim simulations enable automakers and developers…

Continue Reading

Tuesday Nov 22, 2022 - 9:50 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in lieu thereof); the shares were priced at-the-market under NASDAQ rules.…

Continue Reading

Monday Nov 21, 2022 - 2:10 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Discusses Vast Potential of Autonomous Technology in ‘Get Authentic’ Interview

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, was featured in Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary athletes and industry leaders. The company’s chairman and CEO William Santana Li joined the broadcast, hosted by NFL veteran and best-selling author Marques Ogden, to discuss Knightscope’s technology and how…

Continue Reading

Monday Nov 21, 2022 - 12:37 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research, discussed the company’s efforts to investigate the potential therapeutic utility of its proprietary DehydraTECH(TM)-CBD against dementia and diabetes, two of the world’s largest public health crises. Lexaria recently demonstrated DehydraTECH-CBD’s…

Continue Reading

Monday Nov 21, 2022 - 11:05 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue,…

Continue Reading

Monday Nov 21, 2022 - 10:08 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Q3 2022 Earnings Call

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on Monday, Nov. 28. During the webcast, Flora management will deliver financial and operational results for the third quarter ended Sept. 30, 2022, and provide updates on the company’s commercial wholesale…

Continue Reading

Friday Nov 18, 2022 - 12:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients

Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD not only increases the amount of CBD in the blood…

Continue Reading

Friday Nov 18, 2022 - 10:31 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price of $3.30 per share or prefunded warrant. In addition, the…

Continue Reading

Friday Nov 18, 2022 - 10:05 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Discusses Next-Level Technology on Stock Day Podcast

Mullen Automotive (NASDAQ: MULN), a Southern California-based company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the U.S., was featured on a recent episode of the Stock Day Podcast. Mullen’s CEO David Michery joined Stock Day host Everett Jolly to discuss the company’s milestones, partnerships, strategic acquisitions, deliverables, and the successful debut of Mullen’s first electric crossover.…

Continue Reading

Thursday Nov 17, 2022 - 11:41 am

InvestorNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces Next-Gen Lidar Product Honor, New Collaboration

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been recognized for Vista(R)-X120 Plus, its new automotive lidar product. VistaX-120 was named a 2023 honoree in the Vehicle Tech & Advanced Mobility category of the CES Innovation Award program. Cepton plans on unveiling Vista-X120 Plus at CES 2023, which will be held in Las Vegas on Jan. 5-8, 2023. According to…

Continue Reading

Thursday Nov 17, 2022 - 10:25 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Closes on ELMS Asset with $150M Funding

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received $150 million funding, which the company will use in part to close on ELMS assets. According to the announcement, the company can now fund and close on ELMS assets and complete engineering, preparation and launch of EVs. ELMS assets include a factory in Mishawaka, Indiana; all ELMS IP, which includes essential manufacturing data…

Continue Reading

Thursday Nov 17, 2022 - 10:18 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has named Sarah Li as vice president of accounting and InMed controller; the change will be effective Nov. 20, 2022. Li is replacing Brenda Edwards, who has been serving as interim chief financial officer for the company. Edwards joined InMed in the interim contract role in…

Continue Reading

Wednesday Nov 16, 2022 - 3:49 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Four New Client Locations, Continues Impressive Growth Expansion

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), announced the deployment of its proprietary ASRs to four new locations. The new agreement represents the growing reach and versatility that Knightscope offers as it works to protect individuals, property and possessions across an array of different verticals. One new ASR will be providing key surveillance at a leading U.S.-based operator of casinos and…

Continue Reading

Wednesday Nov 16, 2022 - 1:36 pm

InvestorNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Announce Tingo Mobile PLC’s Launch of Key Partnerships

Tingo (OTC: TMNA) and MICT (NASDAQ: MICT) today announced that Tingo Mobile, which is being wholly acquired by MICT with a scheduled completion date of Nov. 30, 2022, has launched its partnership with the All Farmers Association of Nigeria (“AFAN”) ahead of schedule. Through its recently disclosed trade deal with Tingo Mobile, AFAN has committed to deliver a minimum of 20 million additional subscribers, which…

Continue Reading

Wednesday Nov 16, 2022 - 12:11 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks Key Step in Progress Toward Commercializing Medicinal Cannabis

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced the completion of its new laboratory located in Bogota, Colombia. Specializing in the manufacturing of compound formulations utilizing cannabis derivatives and traditional master formulas, Flora Lab 4 will become part of Flora’s group of laboratories. These include existing labs that produce cosmetics, phytotherapeutic products, dietary supplements, and…

Continue Reading

Wednesday Nov 16, 2022 - 11:15 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Featured in Chardan Report, Receives ‘Buy’ Rating

Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“NAFTA”) region, was featured in a recent Chardan report. Chardan is an independent, full-service, global investment bank. The Chardan report is the first analyst coverage that Freight…

Continue Reading

Wednesday Nov 16, 2022 - 11:13 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Featured in New Report Discussing Growth in EV Space

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is grabbing attention in the competitive electric vehicle space. A leading investor resource covering EV stocks, Investor Ideas recently released a special news report about the growth in the EV sector, which featured Mullen, mentioning the company’s Strikingly Different EV Crossover Tour, which features the Mullen FIVE EV Crossover. The report quoted social media EV influencer…

Continue Reading

Wednesday Nov 16, 2022 - 10:57 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the effects of cannabinoid analogs in neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. Prior to this announcement, InMed had identified potential cannabinoid analogs that exhibited promising effects particularly in relation…

Continue Reading

Tuesday Nov 15, 2022 - 1:13 pm

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) ‘Strikingly Different’ EV Crossover Tour Takes the Spotlight in Vegas, Heads to Texas

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has successfully completed the third stop of the Mullen FIVE Strikingly Different EV Crossover Tour in Las Vegas, Nevada. According to the announcement, Mullen continues onwards to Texas, with stops this week in Dallas and Houston. The Mullen FIVE EV vehicle on tour is equipped with a completely updated infotainment system…

Continue Reading

Tuesday Nov 15, 2022 - 12:13 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Q3 2022 Results, Provides Corporate Update

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases, today announced financial results for the third quarter ended Sept. 30, 2022, and provided a corporate update. “Initial, preliminary data from our second patient dosed with CycloSam continues to show positive signals in terms of safety and efficacy. While it is too early…

Continue Reading

Tuesday Nov 15, 2022 - 11:00 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Focused on Improving Commerce Between US and Mexico

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an over-the-road (“OTR”) shipping technology investor based in Houston, Texas. The company is focused on further improving commerce between the United States and Mexico by developing solutions that make the commercial truck industry’s supply chain processes more efficient. “Fr8Tech uses automation and transparent, real-time metrics that are communicated between shippers and qualified carriers – concentrating on cross-border as well…

Continue Reading

Tuesday Nov 15, 2022 - 10:47 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Q2 Results, Recent Business Highlights, Presentation of CYB003 Preclinical Data at Neuroscience 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), has reported unaudited financial results for its second quarter ended Sept. 30, 2022, as well as recent business highlights. “We have continued to make progress as planned, advancing our clinical pipeline of modified psychedelic-based molecules while also strengthening our drug discovery platform of differentiated preclinical compounds,” said Cybin’s CEO Doug…

Continue Reading

Monday Nov 14, 2022 - 3:26 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Finalized Deal to Provide 40-Plus Machines to NJ University

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), continues to sign contracts and agreements as it delivers on its mission to provide safety and security to a growing number of organizations around the country. Most recently, Knightscope has signed a contract with a New Jersey university to deliver 31 K1 Blue Light Towers and 10 K1 Blue Light E-Phones. The new contract…

Continue Reading

Monday Nov 14, 2022 - 3:02 pm

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Strategic Move to Sell Alta Mesa Project, Focus on Uranium and Rare Earth Production

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements (“REE”), today announced its entry into a definitive agreement to sell three wholly owned subsidiaries that together hold its Alta Mesa ISR Project to enCore Energy for total consideration of $120 million (the “transaction”). The transaction, which is expected to close by the end of 2022 or early…

Continue Reading

Monday Nov 14, 2022 - 12:45 pm

InvestorNewsBreaks – Tingo Inc. (TMNA) Announces Strong Q3 2022 Results, Positioned for Continued Growth and Acceleration of Expansion Strategy

Tingo (OTC: TMNA) today announced that it has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three and nine months ended Sept. 30, 2022. Among the highlights, the company reported growth in its Nwassa agri-fintech business that has driven increases of 64.8 % in revenues and 53.9 % in operating profit as compared to Q3 2021. In…

Continue Reading

Monday Nov 14, 2022 - 12:07 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Partners with 357 Company to Launch Cannabis Division

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is working with the 357 Company to launch 357’s Canna Logistics division. The new division is an expansion beyond 357’s Hemp Logistics segment, which ships federally legal hemp within the United States. According to the announcement, the new division will focus on logistics management and shipping of cannabis and…

Continue Reading

Monday Nov 14, 2022 - 9:53 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for the treatment of glaucoma. According to the report, enrollment and…

Continue Reading

Thursday Nov 10, 2022 - 3:32 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Show to Take the Spotlight in Portland, Oregon

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at Legacy Emanuel Medical Center in Portland, Oregon, for the Violence in the Workplace Prevention Summit on Nov. 11, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion.…

Continue Reading

Thursday Nov 10, 2022 - 3:25 pm

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Selects Our Next Energy as Battery Supplier for Electric Commercial Trucks

Mullen Automotive’s (NASDAQ: MULN) majority owned company, Bollinger Motors, today announced that Our Next Energy will be supplying modular, linkable Aries battery packs to power its all-electric commercial platforms and chassis cabs. Bollinger’s all-electric Class 4 through Class 6 chassis cabs are designed to meet the needs of commercial customers in a segment that often requires large payloads, sufficient range, durability, and longevity. “ONE battery…

Continue Reading

Thursday Nov 10, 2022 - 1:15 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First-Ever Study Exploring Therapeutic Use of DehydraTECH-CBD in Dementia

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is starting a new study program — DEM-A22-1 — on Nov. 15, 2022. The study, a first for Lexaria, will evaluate whether LEXX’s DehydraTECH-processed cannabidiol (“CBD”) may have potential for therapeutic treatment for dementia. According to the announcement, Lexaria has previously shown the efficacy of DehydraTECH-CBD in studies focused on human hypertension; the studies showed…

Continue Reading

Thursday Nov 10, 2022 - 12:19 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports Majority of Franchise Global Health (TSX.V: FGH) Shareholders Approve Acquisition

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is one step closer to completing its previously announced acquisition of Franchise Global Health (TSX.V: FGH). FLGC announced that holders of more than 73% of the outstanding shares of FGH have agreed to vote their shares in favor of Flora’s acquisition of FGH; the voting will take place during…

Continue Reading

Thursday Nov 10, 2022 - 12:13 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in…

Continue Reading

Thursday Nov 10, 2022 - 11:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific…

Continue Reading

Thursday Nov 10, 2022 - 10:23 am

InvestorNewsBreaks – Tingo Inc. (TMNA) Announces Launch of Operations in Ghana, Entry into Landmark Trade Deal with the Kingdom of Ashanti

Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed on a landmark trade deal with the Kingdom of Ashanti,…

Continue Reading

Wednesday Nov 09, 2022 - 2:14 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Deploys 25 More ASRs, K1 Blue Light Towers Across the US

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has activated more machines across the country. According to the announcement, the deployed equipment consists of ASRs and one of Knightscope’s newest products, the K1 Blue Light Tower. Deployment locations include another California resort and casino, a privately owned global real estate investment, a development and management firm with 634 properties, a…

Continue Reading

Wednesday Nov 09, 2022 - 1:46 pm

InvestorNewsBreaks – Tingo Inc. (TMNA) Announces Filing of Definitive Information Statement to Merge with MICT

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has filed a Definitive Information Statement with the U.S. Securities and Exchange Commission (“SEC”). The statement outlines the completion of the merger between Tingo Mobile PLC, a wholly owned Tingo subsidiary, with MICT Inc., a NASDAQ-traded financial technology company; the merger should be complete by the end of this month. Once the merger is finalized, MICT will…

Continue Reading

Wednesday Nov 09, 2022 - 1:26 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Inks Distribution Deal for Expansion into Ireland, UK

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has signed a distribution agreement with Newgate Motor Group, one of Ireland’s best-known dealerships. The agreement calls for Newgate to serve as the marketing, sales, distribution and servicing agent for the Mullen I-GO in Ireland and the United Kingdom. As part of the agreement, Newgate will purchase initial units of I-GO for use in vehicle…

Continue Reading

Tuesday Nov 08, 2022 - 12:17 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety and efficacy of DehydraTECH-CBD in human hypertension studies. Strong connections…

Continue Reading

Monday Nov 07, 2022 - 1:53 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).